Jade Biosciences (JBIO) Capital Expenditures (QoQ) (2021 - 2025)
Jade Biosciences (JBIO) Capital Expenditures (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -155.16% |
| Sep 30, 2025 | 1,103.57% |
| Jun 30, 2025 | 53.33% |
| Mar 31, 2025 | -126.55% |
| Dec 31, 2024 | -86.87% |
| Sep 30, 2024 | 168.62% |
| Jun 30, 2024 | -125,300.00% |
| Mar 31, 2024 | -106.25% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | -46.67% |
| Mar 31, 2023 | -98.22% |
| Dec 31, 2022 | 809.28% |
| Sep 30, 2022 | -159.25% |
| Jun 30, 2022 | 1,328.57% |
| Mar 31, 2022 | 315.38% |
| Dec 31, 2021 | -116.67% |